Skip to content

Liver Stiffness combined with LSPS Evaluates the Risk of Esophageal Varices and Bleeding in Patients with HBV-related Liver Cirrhosis

Liver Stiffness combined with LSPS Evaluates the Risk of Esophageal Varices and Bleeding in Patients with HBV-related Liver Cirrhosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17010632
Enrollment
Unknown
Registered
2017-02-14
Start date
2014-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BHV-related cirrhosis

Interventions

Gold Standard:esophageal variceal bleeding(EVB)
for&#32
by&#32
combined&#32
approaches&#32
FibroTouch,&#32
gastroscopy,&#32

Sponsors

Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 76 Years

Inclusion criteria

Inclusion criteria: 1. liver cirrhosis caused by HBV infection; 2. BMI = 35; 3. no previous variceal bleeding; 4. no severe ascites; 5. no previous ß-blocker therapy; and 6. no history of upper gastrointestinal tract bleeding or hepatocellular carcinoma.

Exclusion criteria

Exclusion criteria: 1. any cause of portal hypertension except HBV; 2. severe ascites, which may drastically influence the accurate process of LSM; and 3. unreliable LSM: successful measurements 30%

Design outcomes

Primary

MeasureTime frame
Combined indeces of esophageal variceal bleeding(EVB);

Countries

China

Contacts

Public ContactLing Yang

Tongji Medical College, Huazhong University of Science and Technology

hepayang@163.com+86 13971178791

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026